NAVELBINE

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NAVELBINE contains one active pharmaceutical ingredient (API):

1 Vinorelbine UNII 253GQW851Q - VINORELBINE TARTRATE

Vinorelbine is an antineoplastic drug of the vinca alkaloid family but unlike all the other vinca alkaloids. Vinorelbine inhibits tubulin polymerization and blocks mitosis at G2-M, causing cell death in interphase or at the following mitosis. Read about Vinorelbine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01CA04	Vinorelbine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CA Vinca alkaloids and analogues
Discover more medicines within L01CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4620E, 7263G, 9009E, 9010F
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 507003601152310, 507003602159319, 507003603112316, 507003604119314
Country: EE	Ravimiamet	Identifier(s): 1039979, 1069602, 1456411, 1456422, 1595594, 1595606
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59300, 65978, 65979
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 002943, 003164, 003175, 168997, 169433
Country: FR	Base de données publique des médicaments	Identifier(s): 61168991, 63413635, 64503288, 68184425
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 155170, 48043, 48044, 95226, 95229
Country: HK	Department of Health Drug Office	Identifier(s): 44009, 56212, 56213
Country: IE	Health Products Regulatory Authority	Identifier(s): 88431, 88492
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6500, 6504
Country: IT	Agenzia del Farmaco	Identifier(s): 027865106, 027865118
Country: JP	医薬品医療機器総合機構	Identifier(s): 4240407A1028, 4240407A2024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004236, 1004237, 1065716, 1065717, 1067907, 1067908
Country: MT	Medicines Authority	Identifier(s): AA565/73701
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 625M2003
Country: NL	Z-Index G-Standaard	Identifier(s): 14645971, 14646005
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 118109, 118117, 58815, 58823
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11625, 11626, 7690
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100046499, 100108817, 100108823
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W42512001, W42512002, W42513001, W42513002
Country: SG	Health Sciences Authority	Identifier(s): 06778P, 12546P, 12547P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6063121H, 6063124H, 6063125H, 6063126H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699749190039, 8699749190046, 8699749770019, 8699749770026
Country: US	FDA, National Drug Code	Identifier(s): 64370-532
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/26/0123, 30/26/0124, 36/26/0012, 36/26/0013, 36/26/0014, 36/26/0015